- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02418286
KLOS Study - Korean Medicine Registry for Low Back Pain Patients, a Prospective, Observational, Multicenter, Pilot Study (KLOS)
March 27, 2021 updated by: Yun-Kyung Song, Gachon University Gil Oriental Medical Hospital
The Purpose of this trial is to define the characteristics of the in/outpatients with low back pain in traditional Korean medicine rehabilitation clinic.
This information will create a registry that will help us to compare similarities and differences in patients and their symptoms.
The more patients the investigators are able to enter into the registry, the more the investigators will be able to understand the low back pain and learn better ways of caring for patients.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
KLOS, prospective, multi-center, patient registry pilot study will collaborate with 7 Korean medicine hospitals and plan to recruit low back pain patients into the registry.
150 eligible patients with new episode of LBP who visit Korean medicine hospital without any other treatment history will enroll to the registry.
After enrollment, study collect the individual characteristics of patient's status such as pain intensity, LBP related daily disability, anthropometrics, HRQoL at baseline, 30 and 90 days.
We also access to the patient's clinical and administrative electronic records to analyze the pattern of patients' resource utilization.
Overall, the aims of KLOS are to: 1) explore the general characteristics of new episode of LBP patients and; 2) evaluate the efficacy and safety of various Korean medicine treatments on low back pain based on nationwide registry outcome collecting process.
Study Type
Observational
Enrollment (Actual)
150
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Incheon, Korea, Republic of
- Gachon University, Gil Oriental Medicine Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with low back pain who are visiting oriental rehabiliation clinic
Description
Inclusion Criteria:
- Inpatients with chief complaint of low back pain in Korean medicine rehabilitation center
- Age greater than or equal to 19
- Ability to have normal communication
- Ability to give informed consent
Exclusion Criteria:
- Patients with low back pain which caused by other diseases(ex. lumbar herniated disc-surgery within past 3 months, vertebral fracture, inflammatory spondylitis, spinal infection, metastatic cancer etc.);
- Patient with musculoskeletal pain which is more severe than lower back pain;
- Patients with chronic disease may affect the results of clinical trial;
- Treated with medication for low back pain within past 4 months;
- Participated in other low back pain clinical trials within past 1 month;
- Patients who are Inability to communicate, such as alzheimer's disease or mild cognitive impairment;
- Pregnant women;
- Patients who are judged to be inappropriate for the clinical study by the researchers
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Low Back Pain Participant Registry
Patients with low back pain in traditional Korean medicine rehabilitation clinic
|
There are no specific interventions associated with this registry as it is purely observational study of medical utilization.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline in 'Roland Morris Disability Questionnaire'
Time Frame: at Baseline, 30 days after registration
|
This is a self-reported questionnaire consisting of 24 items reflecting limitations in different activities of daily living attributed to low back pain including walking, bending over, sitting, lying down, dressing, sleeping, self-care and daily activities.
|
at Baseline, 30 days after registration
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline in 'Roland Morris Disability Questionnaire'
Time Frame: at Baseline, 90 days after registration
|
This is a self-reported questionnaire consisting of 24 items reflecting limitations in different activities of daily living attributed to low back pain
|
at Baseline, 90 days after registration
|
Change from Baseline in Numeric Rating Scale of Pain
Time Frame: at Baseline, 30 days after registration and 90 days after registration
|
A 10-point Numerical Pain Rating Scale (NRS; 0: no pain, 10: maximum pain) assesses the patients' current level of pain.
|
at Baseline, 30 days after registration and 90 days after registration
|
Change from Baseline in European Quality of life 5 Dimension
Time Frame: at Baseline, 30 days after registration and 90 days after registration
|
The EQ-5D is an international, standardized, generic instrument for describing and valuing health status.
Participants were asked to indicate which of the following statements best describes their health state.
|
at Baseline, 30 days after registration and 90 days after registration
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Yun-Kyung Song, KMD, PhD, Professor, Gachon University, Gil Oriental Medical Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2015
Primary Completion (Actual)
December 31, 2020
Study Completion (Actual)
December 31, 2020
Study Registration Dates
First Submitted
April 6, 2015
First Submitted That Met QC Criteria
April 15, 2015
First Posted (Estimate)
April 16, 2015
Study Record Updates
Last Update Posted (Actual)
March 30, 2021
Last Update Submitted That Met QC Criteria
March 27, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14-102
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nervous System Diseases
-
Bracco Diagnostics, IncCompletedCentral Nervous System Neoplasms | Central Nervous System Disease
-
Bracco Diagnostics, IncCompletedCentral Nervous System Diseases | Central Nervous System NeoplasmsUnited States
-
Bracco Diagnostics, IncCompletedCentral Nervous System Diseases | Central Nervous System NeoplasmsUnited States
-
UNC Lineberger Comprehensive Cancer CenterRecruitingCentral Nervous System TumorUnited States
-
University of MichiganCompletedAutonomic Peripheral Nervous System DiseasesUnited States
-
Washington University School of MedicineRecruitingCentral Nervous SystemUnited States
-
Weill Medical College of Cornell UniversityRecruitingCentral Nervous System Tumor | Pediatric Central Nervous System TumorUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)WithdrawnBrain and Central Nervous System Tumors
-
The Hong Kong Polytechnic UniversityUnknownAutonomic Nervous System DisorderChina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States